These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12119888)

  • 41. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
    White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
    Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Stomach tolerance of nonsteroidal antirheumatic drugs: comparative endoscopic study].
    Simon B; Dammann HG; Müller P
    Z Rheumatol; 1987; 46 Suppl 1():40-6. PubMed ID: 3125699
    [No Abstract]   [Full Text] [Related]  

  • 43. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Inflammation-induced pain. How rheumatism patients profit from the proper NSAID choice].
    MMW Fortschr Med; 2012 May; 154(8):74-5. PubMed ID: 22693763
    [No Abstract]   [Full Text] [Related]  

  • 45. Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Problems compromise review's validity.
    Juni P; Sterchi R; Dieppe P
    BMJ; 2003 Feb; 326(7384):334; author reply 334. PubMed ID: 12574052
    [No Abstract]   [Full Text] [Related]  

  • 46. Is enteric aspirin safer than regular aspirin?
    Johns Hopkins Med Lett Health After 50; 2013 Aug; 25(7):7. PubMed ID: 24386685
    [No Abstract]   [Full Text] [Related]  

  • 47. Benefits of low-dose corticosteroids in rheumatoid arthritis.
    Cohen MD; Conn DL
    Bull Rheum Dis; 1997 Jun; 46(4):4-7. PubMed ID: 9188203
    [No Abstract]   [Full Text] [Related]  

  • 48. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Arguments in favor.
    Mukherjee D
    Thromb Haemost; 2006 Oct; 96(4):407-12. PubMed ID: 17003915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controversies in COX-2 selective inhibition.
    Simon LS; Smolen JS; Abramson SB; Appel G; Bombardier C; Brater DC; Breedveld FC; Brune K; Burmester GR; Crofford LJ; Dougados M; DuBois RN; Fitzgerald GA; Frishman W; García Rodríguez LA; Hochberg MC; Kalden JR; Laine L; Langman MJ; Prescott SM; van de Putte LB; Whelton A; White WB; Willaims GH
    J Rheumatol; 2002 Jul; 29(7):1501-10. PubMed ID: 12136912
    [No Abstract]   [Full Text] [Related]  

  • 50. [Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"].
    Kellner H
    Krankenpfl J; 2004; 42(5-6):185. PubMed ID: 15527245
    [No Abstract]   [Full Text] [Related]  

  • 51. Coxibs and cardiovascular risk.
    Allen MJ; McLean-Veysey P; Fleming I
    CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098
    [No Abstract]   [Full Text] [Related]  

  • 52. [Celecoxib in the symptomatic treatment of active osteo- or rheumatoid arthritis. Results of a post-marketing surveillance].
    Wigand R; Wehling M; Brauer HG; Stridde E; Vergin H; May M
    Dtsch Med Wochenschr; 2004 May; 129(21):1188-92. PubMed ID: 15160322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ; Wentworth C; Burke TA; Makuch RW
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compliance with guidelines for proton pump inhibitor prescriptions in a department of geriatrics.
    Seite F; Delelis-Fanien AS; Valero S; Pradère C; Poupet JY; Ingrand P; Paccalin M
    J Am Geriatr Soc; 2009 Nov; 57(11):2169-70. PubMed ID: 20121973
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effectiveness and tolerability of celecoxib in outpatient department practice].
    Cancilleri F; Caione G; Di Martino A; Marinozzi A; Stellato GM; Denaro V
    Clin Ter; 2003; 154(1):17-20. PubMed ID: 12854279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis.
    Suárez-Otero R; Robles-San Román M; Jaimes-Hernández J; Oropeza-De La Madrid E; Medina-Peñaloza RM; Rosas-Ramos R; Castañeda-Hernández G
    Proc West Pharmacol Soc; 2002; 45():26-8. PubMed ID: 12434517
    [No Abstract]   [Full Text] [Related]  

  • 57. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
    Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
    Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups.
    Euler AR; Safdi M; Rao J; Jaszewski R; Welsh J; Le V; Raskin J; Fleischmann R; Razzaque M; Champion C
    Gastroenterology; 1990 Jun; 98(6):1549-57. PubMed ID: 2186951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experimental NSAID-associated gastric mucosa injuries].
    Varvanina GG; Tkachenko EV; Drozdov VN; Trubitsyna IE
    Eksp Klin Gastroenterol; 2008; (6):34-5. PubMed ID: 19334425
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapy of joint pain in arthrosis and arthritis. Classical nonsteroidal anti-inflammatory agents, coxibs--or opioids?].
    Neumaier J
    MMW Fortschr Med; 2009 Aug; 151(34-35):22-3. PubMed ID: 19771784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.